Presentations – Spanish HIV Forum-Integrase Inhibitors

 

Day 1 - FRIDAY 8 JUNE

 Session 1  -  State of the Art Update  -  Integrase Inhibitors
 Berenguer, Juan 2017 120State of the ART: Integrase Inhibitors Clinical Data
Juan Berenguer, MD
Hospital General Gregorio Marañón, Madrid

 

 

Jonathan Schapiro, MD

State of the ART: Integrase Inhibitors Resistance (an update)
(Not available)

Jonathan Schapiro, MD
Sheba Medical Center, Israel

 

 Abstract driven presentations 
 Integrase inhibitors and virological failure: a cohort analysis
(Not available)

Montejano, Rocio. Hospital Universitario La Paz, Madrid

01

 Análisis descriptivo de mutaciones asociadas a resistencia (MR) para inhibidores de la integrasa (INI) del VIH en el Hospital Universitario de La Princesa de Madrid
(Not available)

García-Fraile Fraile, Lucio Jesús.
Hospital Universitario De La Princesa, Madrid

02

 Session 2  -  Changing the paradigm: Reduced drug regimens
 Llibre, Josep 2012 120x160What is the Virological support for reduced drug regimens?
Josep M. Llibre, MD, PhD
Hospital Universitari Germans Trias i Pujol, Barcelona

 

 Ribera, Esteban web 120What is the Pharmacological support for reduced drug regimens?
Esteban Ribera, MD, PhD
Hospital Universitari Vall d'Hebron, Barcelona

 

 Taiwo, Babafemi 2018What are the Clinical data for reduced drug regimens?
(Not available)

Babafemi O. Taiwo, MBBS
Northwestern University, USA

 

 Abstract-driven presentations 
 Comparative clinical experience with the two STR co-formulations with integrase inhibitors for the treatment of HIV patients
(Not available)

Hernández García, Guiomar.
Hospital Universitario Príncipe De Asturias, Alcalá De Henares

03

 Eficacia y tolerabilidad del tratamiento con Elvitegravir, Cobicistat, Emtricitabina y Tenofovir Alafenamida (EVG/COBI/FTC/TAF) en pacientes con infección por VIH. Análisis a 24 semanas
(Not available)

Bautista, Azucena.
Hospital De La Princesa, Madrid

04

 Biterapias basadas en Dolutegravir: ¿son una realidad y una necesidad en la práctica clínica diaria?
(Not available)

Ferrer, Ana.
Hospital Clínico Universitario, Valencia

05

 Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study
Troya, Jésus.
Hospital Universitario Infanta Leonor, Madrid

06

 

Day 2 - SATURDAY 9 JUNE

 Session 3  -  Integrase Inhibitors in Routine Care
 Arribas, José 2016 120Optimizing Clinical Care
José Arribas, MD
Hospital Universitario La Paz, Madrid

 

 Sánchez-Conde, Matilde web 120Optimal Clinical Care in special populations
(Not yet available)

Matilde Sánchez Conde, MD
Hospital Universitario Ramón y Cajal, Madrid

 

 Abstract driven presentation 
 Interstitial pneumonia by triple viral co-infection in a CDC C2 HIV- infected patient
Bracke, Carme.
Hospital Germans Trias I Pujol, Badalona

07

 Antela, Antonio 2017Clinical Case presentation
Antonio Antela, MD
Hospital Clínico Universitario de Santiago de Compostela, A Coruña

 

 Session 4  -  Novel delivery systems
 Montes, Maria Luisa (Marisa) 2018 120Integrating novel delivery systems/novel drugs
Maria Luisa Montes, MD, PhD
Hospital Universitario La Paz, Madrid